Infrastructure for Automated IV Compounding Verification

IV compounding verification requires formally documented rules in machine-readable form: acceptable gravimetric tolerance ranges per drug class, barcode validation logic for each drug-diluent pairing, and computer vision thresholds for final product inspection. USP 797/800 and Joint Commission standards mandate these rules exist, but autonomous verification requires them structured beyond policy PDFs—as queryable logic the AI can apply without pharmacist interpretation for each compounding event.

Automated IV compounding verification demands that barcode scan events, gravimetric measurements, camera images, and pharmacist override decisions are captured in real-time from compounding workflows—not logged after the fact. Each verification event must carry complete metadata (compounder ID, order reference, timestamp, measurement values) for the audit trail and discrepancy alerts to function. This is event-driven, workflow-embedded capture, not periodic documentation.

Computer vision and gravimetric verification require formal ontology: Drug entities mapped to acceptable concentration ranges, Diluent.compatibleWith.Drug relationships, tolerance constraints per compounding class (hazardous vs. non-hazardous under USP 800), and barcode-to-NDC mappings. Without explicit entity-relationship schema, the AI can't determine whether a 4% gravimetric variance on a chemotherapy agent represents an error or falls within acceptable tolerance for that specific drug.

The IV compounding verification system requires API access to the pharmacy order management system (to retrieve IV order details), drug database (for NDC-to-drug mapping), and the compounding documentation system (to write the audit trail). These integrations enable real-time verification against the active medication order. Full unified access layer (L4) isn't required because the verification workflow is contained within the pharmacy ecosystem, not requiring cross-enterprise data assembly.

IV compounding verification rules must update when USP standards change, when new chemotherapy agents are added to formulary, or when tolerance thresholds are revised by the P&T committee. Event-triggered maintenance—formulary addition triggers tolerance rule update, USP revision triggers compounding parameter update—is sufficient to keep the system accurate. Near-real-time sync isn't required because compounding parameters change on regulatory/formulary cycles, not continuously.

IV compounding verification operates within a defined pharmacy workflow: the compounding station, pharmacy order system, and drug database. Point-to-point integrations—barcode scanner to verification engine, verification engine to order system, results to audit trail—are sufficient for this capability. The verification process doesn't require cross-enterprise context assembly or an integration platform. The closed pharmacy environment limits integration scope to internal compounding workflow systems.